Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Ipsen and bioMérieux have entered into a global collaboration around theranostics (personalized diagnostic medicine), with a focus on hormone-dependent cancers. The two companies will leverage their expertise and resources to develop a personalized approach to medicine based on Ipsen’s portfolio of compounds and bioMérieux’s diagnostic tests.

The companies will jointly identify programs for the co-development of a therapeutic and a companion diagnostic test, particularly in the prevention and treatment of prostate and breast cancers, neuro-endocrine tumors (NETs) and pituitary tumors.

“We are very pleased to build this partnership with Ipsen, which has developed over the years a significant scientific and medical expertise. Our goal is to reinforce personalized medicine and contribute through this partnership to the novel paradigm in medicine, which is increasingly “patient-driven” rather than “disease-driven”,” said Prof. Christian Bréchot, vice president of Institut Mérieux, in charge of medical and scientific affairs.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters